Science Market Update

$29M Core Grant Awarded to Alabama for Cancer Research Center

Posted by Rebecca Partridge on Wed, Jun 29, 2016

(Image courtesy of Wikimedia commons)

University of Alabama at Birmingham received a $29 million grant from the National Cancer Institute. This five year core grant will support six research programs at the UAB Comprehensive Cancer Center. The renewal of the Cancer Center Support Grant, the most prestigious federal grant that a cancer research and treatment program can earn, also extends UAB’s elite “comprehensive” designation. According to the UAB News website this designation is awarded for scientific excellence and the ability to integrate diverse research approaches in the fight against cancer.

Read More

Tags: Bioresearch funding, cancer research, Alabama, University of Alabama, Cancer Treatment, Cancer, University of Alabama Birmingham, UAlab, UAB, University of Alabama at Birmingham, Cancer Center, cancer researchers, fight cancer, 2016, cancer reserach, Bioresearch Grant, Comprehensive Cancer Center

Construction of New $160M Cancer Research Building Underway at OHSU

Posted by Laura Braden on Mon, Jun 27, 2016

(Image courtesy of Cacophony via Wikimedia Commons)

The Knight Cancer Institute at Oregon Health and Science University, a world-leader in cancer research, recently accomplished raising $1 billion in funding to help support the groundbreaking life science research being conducted at the center.

Read More

Tags: new research building, Oregon Health and Science University, Northwest, cancer research, OR, OHSU, Portland, 2016, BioResearch Product Faire, Western, Knight Cancer Institute

UMich Receives $17.5M Funding for Cancer Research

Posted by Laura Braden on Thu, Jun 23, 2016

The Comprehensive Cancer Center at the University of Michigan, Ann Arbor is one of only 45 comprehensive cancer centers in the United States, and provides cutting-edge cancer research. Researchers from 48 different university departments and 9 schools work together in the cancer center to find answers to some of the toughest questions that scientists face when learning about cancer. The university and Cancer Center will soon be expanding their research capabilities thanks to a generous $17.5 million donation from philanthropists Madeline and Sydney Forbes

Read More

Tags: University of Michigan, Midwest, cancer research, Ann Arbor, MI, UMich, new funding, 2016, BioResearch Product Faire, Comprehensive Cancer Center, Forbes Institute for Cancer Discovery, Madeline and Sidney Forbes

Fred Hutch Researchers Identify Biology-Based Treatment for Lung Cancer

Posted by Laura Braden on Mon, Jun 20, 2016

Small-cell lung cancer (SCLC) makes up about 10 - 15% of all lung cancer diagnoses, and is caused by smoking and inhaling second-hand smoke. This is an aggressive type of cancer that spreads quickly, and recurs extremely frequently after patients undergo chemotherapy treatments. Treatments for SCLC have not changed much in the past 30 years, but a team of researchers led by the Fred Hutchinson Cancer Research Center in Seattle has been investigating potential new therapy methods for the cancer and recently uncovered a gene that has the potential to be used in biology-based treatments for SCLC. (Image courtesy of Lindsay Fox via Wikimedia Commons and EcigaretteReviewed)

Read More

Tags: Fred Hutchinson Cancer Research Center, WA, cancer research, Seattle, Hutch, 2016, Fred Hutch, BioResearch Product Faire, Western, small-cell lung cancer, L-Myc, SCLC

Cancer Fighting Antibody Created by Duke Researchers

Posted by Laura Braden on Fri, Jun 10, 2016

Antibodies are essential for keeping the body healthy, as they are produced in the immune system and sent to fight harmful substances. Since they are essential for fighting off unwanted antigens in the body, antibodies are a hot topic that researchers are constantly studying. Recently, a research team from Duke University developed an antibody that specifically targets cancer cells, providing a possible new immunotherapy for cancer. (Image of antibody-antigen complex courtesy of Alejandro Porto via Wikimedia Commons)

Read More

Tags: Duke University, cancer research, Durham, NC, Duke, Antibodies, BioResearch Product Faire, cancer therapy, eastern, CFH

UChicago and Evelo Biosciences to Develop New Cancer Immunotherapy

Posted by Laura Braden on Wed, Jun 08, 2016

Researchers around the world are constantly studying ways to create new treatment methods to fight cancer. With so many different forms of cancer, using one treatment method is not always effective for everyone battling this disease. Recently, a team of scientists in Chicago teamed up to create a new treatment method. Researchers from the University of Chicago and the biotechnology company Evelo Biosciences have partnered to develop a new microbiome-based immunotherapy treatment method for fighting cancer. 

Read More

Tags: Midwest, microbiome, immunotherapy, University of Chicago, cancer research, Chicago, Front Line event, IL, UChicago, 2016, BioResearch Product Faire, cancer therapy, Evelo Biosciences, microbiome immunotherapy

Harvard Researchers Use Zebrafish to Observe Origin of Cancer Cells

Posted by Katheryn Rein on Tue, Apr 26, 2016

Cancer Research UK released a staggering statistic in 2014: 46% of people who have cancer are diagnosed during stages 3 or 4; these late stage diagnoses greatly reduce the chances of survival, as treatment success drops once cancer has progressed to such an advanced stage. 

Read More

Tags: Harvard University, cancer research, Massachusetts, Boston, MA, Zebrafish

Berkeley Researchers Team Up for $7.5M Immunotherapy Initiative

Posted by Laura Braden on Thu, Apr 21, 2016

The University of California, Berkeley is a leading research institution, producing promising research in all divsions of the life sciences. To help further research in immunotherapy and cancer, researchers from the University of California, Berkeley have recently teamed up with the Berkeley-based biotech company, Aduro Biotech Inc., for a $7.5 million immunotherapy initiative. This Immunotherapeutics and Vaccine Research Initiative (IVRI) will provide three years of funding to infectious disease researchers studying new techniques for combating both infections and cancer.  

Read More

Tags: CA, University of California Berkeley, immunotherapy, cancer research, vaccine research, Southwest, researchers, UC Berkeley, new funding, UCBerk, 2016, BioResearch Product Faire, Aduro Biotech

Harvard and Merck Partner for $20M Cancer Therapeutics Research

Posted by Laura Braden on Mon, Apr 18, 2016

Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.

Read More

Tags: Harvard University, Northeast, Leukemia, cancer research, Massachusetts, Boston, BioResearch Product Faire Event, MA, Harvard, longwood, 2016, cancer therapy, Merck

Minnesota Research Shows Potency of Kava Against Lung Cancer

Posted by Sam Asher on Fri, Apr 08, 2016

Study Shows Chemopreventative Potential of Kava-Derived Compound

"ALCOHOL IS SO 2014. TRY KAVA!

suggests a sandwich board on Tenth Street between First Avenue and Avenue A, in the East Village.

Sometimes, the most simple and elegant solution to a problem has already been known for centuries. In 2014, University of Minnesota researchers explored the medicinal capacity of an ancient plant -  Piper methysticum, c ommonly known as kava. However, concerns about kava being toxic to the liver have resulted in diminished use. Now, a recently published study has found that a specific kava derivative may have potential to combat cancer without causing any damage to liver cells.
 
 

More Research and Cancer articles:

Read More

Tags: Midwest, University of Minnesota, cancer research, Minnesota, University of Minnesota Twin Cities, Cancer, BioResearch Product Faire Event, Minneapolis, MN, UMinn, 2016, lung cancer

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News